Skip to content

Prevent Return of Stroke Study

Preventing Recurrence of All Inner-city Strokes Through Education

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01027273
Enrollment
600
Registered
2009-12-07
Start date
2009-06-30
Completion date
2013-02-28
Last updated
2014-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke Recurrence, Transient Ischemic Attack

Keywords

Stroke, Ischemic Stroke, Transient Ischemic Attack, Stroke Recurrence Prevention, Cerebrovascular Disorders, Brain Ischemia, Brain Infraction, Brain Diseases, Cerebral Infraction, Self-management, Peer-led, Community Based

Brief summary

The purpose of this study is to evaluate if a peer-led stroke recurrence prevention intervention, versus usual care, will help reduce risk factors for recurrent strokes among adults in Harlem.

Detailed description

Twenty nine percent of the 700,000 strokes that occur yearly nationwide are among stroke survivors. Blacks, both nationally and among Harlem residents, have a twofold increase in recurrent strokes. Harlem Latinos have a threefold increase in risk relative to Whites. Primary risk factors for recurrent stroke include hypertension, hyperlipidemia, and under use of anti-thrombotic agents. Controlling risk factors can be particularly challenging for low-income, minority populations who lack the resources needed to adhere to necessary therapies. In Harlem, 72% of adults studied six months post stroke did not have these three risk factors treated adequately. We propose to determine if participation in a recurrent stroke prevention educational intervention, versus usual care, can activated stroke survivors to at reduce primary risk factors for recurrent strokes while providing an effective, low-cost, sustainable recurrent stroke prevention program in neighborhoods like Harlem, whose residents bear a disproportionate burden of suffering from strokes. Specifically, we propose: 1. Recruit 600 adults who sustained a stroke or transient ischemic attack (TIA) within the past five years by working with Harlem community leaders, local clinical sites including the Mount Sinai Medical Center and the Institute for Family Health, and the Visiting Nurse Service of New York; 2. To conduct a randomized, controlled trial to determine if participation in a peer-led stroke prevention program activates stroke and TIA survivors to improve their knowledge and self-management strategies and treatments related to stroke prevention; and 3. To rigorously compare the impact of the intervention with usual care (delayed intervention), on increasing the proportion of individuals with strokes and TIAs who are appropriately treated to reduce the risk of recurrent events, specifically through control of hypertension (blood pressure ≤ 140/90mmHg), hyperlipidemia (LDL cholesterol≤100 mg/dl) and use of anti-thrombotic medicines.

Interventions

BEHAVIORALPrevent Return of Stroke

Prevent Return of Stroke is a community-based, peer-led stroke recurrence prevention program. This is a bilingual (English/Spanish) education program written at a 4th grade reading level, and contains simple, actionable, messages, easily taught by lay leaders, and focuses on enhancing self-efficacy to make lifestyle changes, to help reduce stroke recurrence risk factors. It consists of 6 sessions (1½ hours each) held over 6-weeks. Topics include learning the risk factors for stroke, controlling hypertension, LDL cholesterol, preventing blood clots, medication adherence, and stress management.The intervention arm will participate in the intervention shortly after enrolling in the trial.

Sponsors

National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH
North General Hospital, New York
CollaboratorOTHER
Stanford University
CollaboratorOTHER
Icahn School of Medicine at Mount Sinai
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Had a stroke or TIA diagnosed within 5 years * 40 years of age or older * Able to participate in group education classes * English or Spanish speaking * Community dwelling

Exclusion criteria

* No incidence of stroke or TIA * Stroke or TIA occurred more than 5 years ago * less than 40 years of age * Cognitive or physical impairment that would preclude comprehension of a conversation and communicating as part of a group (i.e., dementia, deafness, inability to speak, aphasia) * Self-reported terminal illness with life expectancy of less than 1 year * Plans to relocate from New York City within one year of enrollment * Pregnant * Nursing home resident * Prisoner

Design outcomes

Primary

MeasureTime frameDescription
Blood Pressure6 months post enrollment into trialPercentage of Participants with Blood Pressure controlled at \<140/90 mm Hg
LDL Cholesterol6 months post enrollment into trialPercentage of participants with controlled Low Density Lipoprotein low (LDL) of less than 100 mg/dL
Use of Anti-thrombotic Medication6 months post enrollment into trialNumber of participants taking anti-thrombotic medication

Secondary

MeasureTime frameDescription
Knowledge and Attitudes About Stroke Recurrence Risk6 months post enrollment into trial
Access to Medical Care6 months post enrollment into trialNumber of participants who have a primary care doctor
Medication Adherence6 months post enrollment into trialNumber of participants adherent to medications as determined with Morisky score ≥ 6 Adherence to medications was measured using the 8-item Morisky Medication Adherence Questionnaire (Morisky). The questionnaire has been validated against an objective measure of adherence and has been used in racially diverse and elderly patient samples. Scores on the questionnaire can be used to classify patients into low and high adherence groups. Consistent with standard cut points, participants who scored less than 6 points on the Morisky were categorized as nonadherent to medications and participants who scored 6 to 8 points were categorized as adherent.
Emotional Health6 months post enrollment into trialNumber of participants diagnosed as depressed utilizing depression scale. Participant is determined to be depressed if Patient Health Questionnaire (PHQ8) ≥ 10. Scale has a total score between 0 and 24 points. A total score of 0 to 4 represents no significant depressive symptoms. A total score of 5 to 9 represents mild depressive symptoms; 10 to 14, moderate; 15 to 19, moderately severe; and 20 to 24, severe.

Countries

United States

Participant flow

Recruitment details

Participants were enrolled from June 2009 to June 2012 recruited at community based sites as well as clinical sites.

Participants by arm

ArmCount
Peer-Led Stroke Recurrence Prevention Education
The intervention group participated in a 6-session course held over a 6-week period. The Prevent Return of Stroke Workshop, led by trained peer educators, aimed to help participants control the risk factors for stroke, thereby preventing recurrence of strokes. Prevent Return of Stroke: Prevent Return of Stroke is a community-based, peer-led stroke recurrence prevention program. This is a bilingual (English/Spanish) education program written at a 4th grade reading level, and contains simple, actionable, messages, easily taught by lay leaders, and focuses on enhancing self-efficacy to make lifestyle changes, to help reduce stroke recurrence risk factors. It consists of 6 sessions (1½ hours each) held over 6-weeks. Topics include learning the risk factors for stroke, controlling hypertension, LDL cholesterol, preventing blood clots, medication adherence, and stress management.The intervention arm will participate in the intervention shortly after enrolling in the trial.
301
Usual Care (Delayed Intervention)
The control group was offered the chance to take part in the 6-week session intervention after 12 months after enrollment into the trial. Prevent Return of Stroke: The intervention arm participated in the intervention shortly after enrolling in the trial. The usual care arm was offered the intervention after 12 months from enrolling in the trial.
299
Total600

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath22
Overall StudyLost to Follow-up5731

Baseline characteristics

CharacteristicPeer-Led Stroke Recurrence Prevention EducationUsual Care (Delayed Intervention)Total
Age, Continuous63 years
STANDARD_DEVIATION 11
64 years
STANDARD_DEVIATION 11
63 years
STANDARD_DEVIATION 11
Sex: Female, Male
Female
180 Participants177 Participants357 Participants
Sex: Female, Male
Male
121 Participants122 Participants243 Participants
Years since stroke1.8 years
STANDARD_DEVIATION 1.4
1.8 years
STANDARD_DEVIATION 1.5
1.8 years
STANDARD_DEVIATION 1.5

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 3010 / 299
serious
Total, serious adverse events
0 / 3010 / 299

Outcome results

Primary

Blood Pressure

Percentage of Participants with Blood Pressure controlled at \<140/90 mm Hg

Time frame: 6 months post enrollment into trial

ArmMeasureValue (NUMBER)
Peer-Led Stroke Recurrence Prevention EducationBlood Pressure76 percentage of participants
Usual Care (Delayed Intervention)Blood Pressure65 percentage of participants
Primary

LDL Cholesterol

Percentage of participants with controlled Low Density Lipoprotein low (LDL) of less than 100 mg/dL

Time frame: 6 months post enrollment into trial

ArmMeasureValue (NUMBER)
Peer-Led Stroke Recurrence Prevention EducationLDL Cholesterol59 percentage of participants
Usual Care (Delayed Intervention)LDL Cholesterol57 percentage of participants
Primary

Use of Anti-thrombotic Medication

Number of participants taking anti-thrombotic medication

Time frame: 6 months post enrollment into trial

ArmMeasureValue (NUMBER)
Peer-Led Stroke Recurrence Prevention EducationUse of Anti-thrombotic Medication199 participants
Usual Care (Delayed Intervention)Use of Anti-thrombotic Medication226 participants
Secondary

Access to Medical Care

Number of participants who have a primary care doctor

Time frame: 6 months post enrollment into trial

Population: 1 missing response from Usual Care group

ArmMeasureValue (NUMBER)
Peer-Led Stroke Recurrence Prevention EducationAccess to Medical Care232 participants
Usual Care (Delayed Intervention)Access to Medical Care240 participants
Secondary

Emotional Health

Number of participants diagnosed as depressed utilizing depression scale. Participant is determined to be depressed if Patient Health Questionnaire (PHQ8) ≥ 10. Scale has a total score between 0 and 24 points. A total score of 0 to 4 represents no significant depressive symptoms. A total score of 5 to 9 represents mild depressive symptoms; 10 to 14, moderate; 15 to 19, moderately severe; and 20 to 24, severe.

Time frame: 6 months post enrollment into trial

ArmMeasureValue (NUMBER)
Peer-Led Stroke Recurrence Prevention EducationEmotional Health46 participants
Usual Care (Delayed Intervention)Emotional Health59 participants
Secondary

Knowledge and Attitudes About Stroke Recurrence Risk

Time frame: 6 months post enrollment into trial

Secondary

Medication Adherence

Number of participants adherent to medications as determined with Morisky score ≥ 6 Adherence to medications was measured using the 8-item Morisky Medication Adherence Questionnaire (Morisky). The questionnaire has been validated against an objective measure of adherence and has been used in racially diverse and elderly patient samples. Scores on the questionnaire can be used to classify patients into low and high adherence groups. Consistent with standard cut points, participants who scored less than 6 points on the Morisky were categorized as nonadherent to medications and participants who scored 6 to 8 points were categorized as adherent.

Time frame: 6 months post enrollment into trial

ArmMeasureValue (NUMBER)
Peer-Led Stroke Recurrence Prevention EducationMedication Adherence159 participants
Usual Care (Delayed Intervention)Medication Adherence169 participants

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026